Articles

Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life

National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo
Department of Oncology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B cell malignancies, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo
Department of Oncology, St. Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim
Department of Oncology, University Hospital of North Norway, Tromso
Regional Advisory Unit for Palliative Care and European Palliative Care Research Centre (PRC), Dept. of Oncology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo
Department of Behavioural Medicine, Faculty of Medicine, University of Oslo, Oslo
Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo
Department of Pediatric and Adolescent Medicine, Akershus University Hospital, Lorenskog
Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen
Department of Research, Cancer Registry of Norway, Oslo
Department of Respiratory Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo
National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo
National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, Oslo
Haematologica Early view Apr 28, 2022 https://doi.org/10.3324/haematol.2021.280413